BOCH
MREO

Blue Owl Capital Holdings’s Mereo BioPharma MREO Stock Holding History

Blue Owl Capital Holdings’s Portfolio MREO Stock Details MREO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,250,000
Closed -$2.58M – 85
2025
Q3 		$2.58M Buy
+1,250,000
New +$2.3M 0.8% 30
2025
Q1 		– Sell
-672,809
Closed -$2.35M – 77
2024
Q4 		$2.35M Sell
672,809
-175,000
-21% -$688K 0.54% 30
2024
Q3 		$3.48M Sell
847,809
-50,000
-6% -$207K 0.67% 32
2024
Q2 		$3.23M Buy
+897,809
New +$2.91M 0.9% 24

Other funds holding MREO

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Blue Owl Capital Holdings's MREO Position: Q4 2025 in Review

Blue Owl Capital Holdings sold out of Mereo BioPharma (MREO) in Q4 2025, closing a stake of 1,250,000 shares — an estimated $2.58M sold.

Blue Owl Capital Holdings first reported a position in MREO in Q2 2024 and held it in 4 quarters. The position peaked at $3.48M in Q3 2024. 70 funds tracked by Wall St. Rank hold MREO as of Q4 2025.

  • Blue Owl Capital Holdings reported no remaining Mereo BioPharma position as of Q4 2025 after selling out during the quarter.
  • Blue Owl Capital Holdings sold 1,250,000 Mereo BioPharma shares in Q4 2025, an estimated $2.58M.
  • Blue Owl Capital Holdings first reported a position in Mereo BioPharma in Q2 2024 and held it in 4 quarters.
  • Blue Owl Capital Holdings's Mereo BioPharma position peaked at $3.48M in Q3 2024.
  • 70 funds tracked by Wall St. Rank held Mereo BioPharma as of Q4 2025.

Based on Blue Owl Capital Holdings's 13F filing for Q4 2025, filed 9 Feb 2026.